Structure Therapeutics Announced A Private Placement Of 21.6M Shares And 2.4M Newly Designated Non-voting Shares At $12.49/Share, With Gross Proceeds Of Approximately $300M
Portfolio Pulse from Benzinga Newsdesk
Structure Therapeutics has announced a private placement of 21.6 million shares and 2.4 million newly designated non-voting shares at $12.49 per share. The gross proceeds from this placement are expected to be approximately $300 million.
September 29, 2023 | 11:37 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Structure Therapeutics' private placement of shares could potentially impact the stock price of GPCR, if it is indeed mentioned in the article.
The news of Structure Therapeutics' private placement could potentially impact the stock price of GPCR, if it is indeed mentioned in the article. However, without specific details on how GPCR is involved, it's difficult to predict the exact impact.
CONFIDENCE 50
IMPORTANCE 50
RELEVANCE 50